N Engl J Med November 2020 PMID 32865380

Colchicine in Patients with Chronic Coronary Disease.

Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink, Donald Latchem, Pieter Hoogslag, Anastazia Jerzewski, Peter Nierop, Alan Whelan

Mentions

378
Peak: 67 in Nov 2020
across 5 sources since Aug 2020

Extended reach

1,259,560
potential audience

Total likes

3,318

Video views

100,113

Mentions per month

Aug 2020 – Oct 2025

Where it's discussed

  • X / Twitter209 posts
  • News147 articles
  • Facebook10 posts
  • Blogs9 articles
  • YouTube3 videos

AI synopsis

What people are saying

Several discussions highlight specific outcomes, such as the significant reduction in cardiovascular events (HR 0.69) observed in patients taking colchicine. Users frequently reference the details of the trial, mentioning the increased risk of non-cardiovascular mortality as a notable point of concern. Terms like 'game changer' and references to new treatment guidelines indicate a tone of both excitement and caution, as participants weigh the benefits against potential risks, contributing to the overall positive sentiment regarding the study's impact on future clinical practice.

AgreementModerate agreement

Many discussions express supportive views about the effectiveness of colchicine in reducing cardiovascular events, indicating a general consensus on its application in clinical settings.

InterestHigh interest

Participants show a high level of interest in the findings of the study, evidenced by numerous comments and explorations of its implications for treatment.

EngagementHigh engagement

Posts reflect deep engagement, with users discussing research methodologies, citing specific trials, and considering the broader clinical context of the findings.

ImpactHigh impact

The publication is perceived as having a significant impact on treatment guidelines and clinical practices regarding chronic coronary disease.

Abstract in brief

  • Recent trial results indicate that colchicine can significantly lower cardiovascular event risks in patients with chronic coronary disease.
  • A total of 5522 patients were involved, with 2762 receiving colchicine and 2760 receiving a placebo, during an average follow-up of 28.6 months.
  • Colchicine reduced the occurrence of primary and key secondary cardiovascular events compared to placebo, but there was a noted increase in non-cardiovascular mortality in the colchicine group.

Top posts

Most liked on X and Bluesky
Dr. FEVI
@javier20ch · X

May 17, 2023 · 49 likes · 8 shares · 13,428 followers View post →
Dr. Ilin Gilberto de la Torre M.
@IlindelatorreMD · X

https://t.co/bxlHDHsXr4 https://t.co/prJt6BGESy

Jun 30, 2023 · 34 likes · 6 shares · 45,844 followers View post →
昭和医科大学病院リウマチ膠原病内科 Div Rheumatol, Showa Med U
@rheum_showa · X

心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.69(95%CI 0.57-0.83) https://t.co/oU7XZPICEy https://t.co/JkwA5Z96CB

Jun 25, 2023 · 25 likes · 6 shares · 3,077 followers View post →
Dr. Norteño
@DrNorteno · X

La evidencia de un ensayo reciente ha demostrado que los efectos antiinflamatorios de la colchicina reducen el riesgo de eventos cardiovasculares en pacientes con infarto de miocardio reciente. N Engl J Med 2020; 383: 1838-1847 DOI: 10.1056 / NEJMoa2021372 https://t.co/T2RzuLupZk

Nov 20, 2020 · 24 likes · 1 share · 6,299 followers View post →
ACCP Cardiology PRN
@accpcardprn · X

Let's start a discussion about colchicine in CAD. We have some decent data showing improvement in outcomes for chronic and acute CAD (see: https://t.co/JllJuLdxJm, https://t.co/zE48m7YtCB). Has anyone adopted this into practice? Why or why not? #CardioTwitter #Cardiology

Jan 10, 2022 · 23 likes · 1 share · 9,300 followers View post →
DoctorTro
@DoctorTro · X

Sep 18, 2023 · 22 likes · 3 shares · 161,071 followers View post →

All mentions

ミミック
@mimic_rheum · X

少々古いですが、NEJMから 慢性冠動脈疾患患者を対象とした無作為化試験で、コルヒチン 0.5 mg の 1 日 1 回の投与を受けた患者は、プラセボの投与を受けた患者よりも心血管イベントのリスクが有意に低かった https://t.co/MQ68ipnwgQ

Oct 3, 2025 · 4 followers View post →
د/عبدالله القرني Abdullah Algarni
@abaidalgarni · X

@eH_Khal @Banitoto Three Rx studied, Positive results=Canakinumab Negative results=Methotrexate https://t.co/ygEUls5dLL Conflicting data=Colchicine https://t.co/hYVoiEqKMj Only colchicine approved for this purpose in high risk pts.

Dec 22, 2024 · 1 like · 2,014 followers View post →
#LeadOnNCDs
@WePublicHealth · X

RT @CroakeyNews: Talking about colchicine administered for coronary disease - why not develop a new drug? #MM2024AdPha https://t.co/aUHD2…

Nov 17, 2024 · 2 shares · 14,465 followers View post →
Melissa Sweet
@MelissaSweetDr · X

RT @CroakeyNews: Talking about colchicine administered for coronary disease - why not develop a new drug? #MM2024AdPha https://t.co/aUHD2…

Nov 15, 2024 · 2 shares · 28,532 followers View post →
Croakey News
@CroakeyNews · X

Talking about colchicine administered for coronary disease - why not develop a new drug? #MM2024AdPha https://t.co/aUHD2KaS1G

Nov 15, 2024 · 2 shares · 11,526 followers View post →
M. Bolton
@5_utr · X

@fischman_david @crfheart No, what about LoDoCo2? https://t.co/p8EL9gHKLN

Oct 29, 2024 · 2,379 followers View post →
Professor M Z Khalil
@mzkhalil · X

Colchicine in Patients with Chronic Coronary Disease | NEJM The incidence of death from noncardiovascular causes was higher in the colchicine group than in the placebo group… https://t.co/HPoq7bTyxn https://t.co/DQ4oDNCmpr

Oct 19, 2024 · 2,856 followers View post →
CardiacJoshi
@cardiacjoshi · X

@DrTrentAllen @dr_shai @TheEMboardround There are a couple of decently powered clinical trials that demonstrate, at low dose, a reduction in MI in pts with CAD. I actually use quite a bit and it's usually well tolerated at the relevant dose. https://t.co/h5qtFz1eGX https://t.co/GtNPETKf55

Oct 18, 2024 · 2 likes · 151 followers View post →
Negar Feizitalarposhti
@FtNegar · X

Jun 29, 2024 · 1 like · 225 followers View post →
Marios Georgakis
@MariosGeorgakis · X

Low-dose oral colchicine (0.5 mg/d) was tested in two phase 3 trials of patients with CAD and also showed meaningful reductions in CV risk COLCOT (post-MI): https://t.co/zQRmSuopcn LoDoCo2 (chronic CAD): https://t.co/lwIVM5yNGw https://t.co/NX53XKlZkN

May 19, 2024 · 1 like · 4,313 followers View post →
Gerard Hough
@GerardHough · X

@HarrySpoelstra https://t.co/0eNZOSzNoU https://t.co/HBd8i3vDzy

Apr 22, 2024 · 4 likes · 1,745 followers View post →
CardioAddict
@CARDIOADDICT88 · X

the risk of cardiovascular events was significantly lower among those who received 0.5 mg of colchicine once daily than among those who received placebo Colchicine in Patients with Chronic Coronary Disease (LoDoCo2 Trial)| NEJM https://t.co/vfSpeyhoVq

Feb 25, 2024 · 1 followers View post →
まる
@standardtherap · X

RT @KazBowen: このあたりの論文が根拠・3割ぐらいLow dose コルヒチンで動脈硬化絡みのMajor eventが減る https://t.co/YHFAayB4Fi

Sep 25, 2023 · 1 share · 2,638 followers View post →
Kazz.MD.Ph.D.
@KazBowen · X

このあたりの論文が根拠・3割ぐらいLow dose コルヒチンで動脈硬化絡みのMajor eventが減る https://t.co/YHFAayB4Fi

Sep 25, 2023 · 11 likes · 1 share · 13,062 followers View post →
jennifer nelson
@jenniferxnelson · X

RT @DoctorTro:

Sep 18, 2023 · 3 shares · 67 followers View post →
Wauna
@waunachadwick · X

RT @DoctorTro:

Sep 18, 2023 · 3 shares · 38 followers View post →
AntonioC Martinez II
@usambcuba · X

RT @DoctorTro:

Sep 18, 2023 · 3 shares · 4,091 followers View post →
DoctorTro
@DoctorTro · X

Sep 18, 2023 · 22 likes · 3 shares · 161,071 followers View post →
John Cripps
@JCrippsSciGuy · X

RT @DoctorTro:

Sep 18, 2023 · 1 share · 427 followers View post →
DoctorTro
@DoctorTro · X

Sep 18, 2023 · 1 share · 161,071 followers View post →
岡村勇輝 Yuki T. Okamura
@okamura_yt · X

https://t.co/o7z0mQqZcS 冠動脈疾患のある5522患者に対するコルヒチン vs placeboのdouble-blinded RCT. 28.6ヶ月追跡、心血管イベントがコルヒチン群で減少(HR 0.69)。ヒト心血管疾患における慢性炎症のcausal roleを示したstudy。 NEJM, 2020.

Sep 17, 2023 · 6 followers View post →
Abdulla A. Damluji, MD, PhD
@DrDamluji · X

13.

Aug 18, 2023 · 15,837 followers View post →
Tariq Mir
@TSM_Humanist · X

@Ecoxx21 @walinjom https://t.co/fvvXxbyLqS

Aug 11, 2023 · 7,499 followers View post →
محار كساسبة
@oyster_99 · X

2023 AHA guidelines recommended (2B) the addition of low dose colchicine in patients with chronic coronary disease for secondary prevention and reduction of recurrent ASCVD events.

Aug 9, 2023 · 3 likes · 76 followers View post →
Hob Gadling
@OliveChirper · X

@Drlipid LoDoCo2 already demonstrates this directly https://t.co/K8s0KWZFGD https://t.co/bHj7Zjf65M

Aug 1, 2023 · 1 like · 275 followers View post →
Reza Ghanavati, MD.
@Ghanavati_r · X

4/5 LoDoCo2 ⚖️ (Randomized, double-blind, placebo controlled trial)

Jul 22, 2023 · 1 like · 326 followers View post →
Beverly G. Tchang, MD
@BevTchangMD · X

@MichaelJBlaha

Jul 22, 2023 · 1 like · 6,116 followers View post →
Syed Shaaban
@ShaabanSyed · X

RT @andreagallardo: “An old drug for a new CV indication”. ✅ Low dose colchicine in patients with chronic coronary disease ⤵️ Cardiovascu…

Jul 10, 2023 · 6 shares · 160 followers View post →
Chidambara .ML.
@chidambara09 · X

RT @yajadev: Colchicine in Patients with Chronic Coronary Disease | NEJM LoDoCo Trial #MedTwitter https://t.co/nIRUK0x22B

Jul 9, 2023 · 1 share · 11,713 followers View post →
AJ
@theajaydevb · X

Colchicine in Patients with Chronic Coronary Disease | NEJM LoDoCo Trial #MedTwitter https://t.co/nIRUK0x22B

Jul 9, 2023 · 3 likes · 1 share · 278 followers View post →
AnaLuisa
@ALui96 · X

RT @IlindelatorreMD: https://t.co/bxlHDHsXr4 https://t.co/prJt6BGESy

Jul 1, 2023 · 6 shares · 65 followers View post →
Jorge Josué
@JJosueRudePunk · X

RT @IlindelatorreMD: https://t.co/bxlHDHsXr4 https://t.co/prJt6BGESy

Jul 1, 2023 · 6 shares · 39 followers View post →
Dr. Eloysis Mosquera
@Eloy_Mosquera · X

RT @IlindelatorreMD: https://t.co/bxlHDHsXr4 https://t.co/prJt6BGESy

Jun 30, 2023 · 6 shares · 241 followers View post →
Dr. Ilin Gilberto de la Torre M.
@IlindelatorreMD · X

https://t.co/bxlHDHsXr4 https://t.co/prJt6BGESy

Jun 30, 2023 · 34 likes · 6 shares · 45,844 followers View post →
こまめ
@hema_to_palli · X

RT @rheum_showa: 心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.…

Jun 26, 2023 · 6 shares · 70 followers View post →
山本陵平
@yamamotoryohei_ · X

RT @rheum_showa: 心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.…

Jun 26, 2023 · 6 shares · 214 followers View post →
moleskine
@moleskine8 · X

RT @rheum_showa: 心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.…

Jun 26, 2023 · 6 shares · 513 followers View post →
近藤 雅人
@mkondo_showa · X

RT @rheum_showa: 心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.…

Jun 25, 2023 · 6 shares · 1,647 followers View post →
果ての大学免疫学者
@meitianyaxiao11 · X

RT @rheum_showa: 心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.…

Jun 25, 2023 · 6 shares · 132 followers View post →
昭和医科大学病院リウマチ膠原病内科 Div Rheumatol, Showa Med U
@rheum_showa · X

心血管イベント予防目的のコルヒチン0.5mg/day投与をFDAが許可 https://t.co/SItNZvNe6A 2020NEJMのRCT:心血管イベントを有意に低下 ・コルヒチン→ 6.8% ・プラセボ → 9.6%  ⇨HR 0.69(95%CI 0.57-0.83) https://t.co/oU7XZPICEy https://t.co/JkwA5Z96CB

Jun 25, 2023 · 25 likes · 6 shares · 3,077 followers View post →
Will Brink
@WillBrink · X

Anti inflammatory agent Colchicine in patients with chronic coronary disease "...risk of cardiovascular events was significantly lower" in those receiving the med: https://t.co/aQQ968D2ZW @NutritionMadeS3 @Drlipid @JohnKastelein @DrMichaelSagner @Lipoprotein @drpablocorral

Jun 25, 2023 · 3 likes · 3,617 followers View post →
Ronaldo Correa Fabiano
@Ronaldo_CFF · X

5/5 Great reviews: https://t.co/Z4H3q4tnZv https://t.co/LFlRvYHnYC @CardioNerds @ACCinTouch @JAMACardio @cardio

Jun 23, 2023 · 5 likes · 832 followers View post →
Vineet Sankhla
@vineetcardio · X

RT @thePagerNews:

Jun 21, 2023 · 1 share · 1,410 followers View post →
Academic Heart
@AcademicHeart · X

Jun 21, 2023 · 4 likes · 1 share · 1,076 followers View post →
Juan Senior
@jsenior64 · X

@GermanSalgado22 @osmarperse @gonzaeperez @drpablocorral @JoseJuanatey @jpcostabel @valentin_vioj Entiendo que básicamente está sustentado en los resultados del estudio LoDoCo 2 en pacientes con síndrome coronario crónico clínicamente estable al menos por 6 meses. https://t.co/clD9WgENDM

Jun 21, 2023 · 2 likes · 11,066 followers View post →
David R. Axline, MD, FACC
@PU84 · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/GcAuLor7YT

Jun 21, 2023 · 1 like · 540 followers View post →
andres
@palacioendocrin · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/ppc13h7mwD

Jun 20, 2023 · 344 followers View post →
Sanjay Kaul
@kaulcsmc · X

2/ Approval is based on LoDoCo2 trial. MACE (PEP): 0.69, 0.57-0.83 CV death: 0.80, 0.44-1.44 MI: 0.70, 0.53-0.93 Stroke: 0.66, 0.35-1.25 Cor. revasc: 0.75, 0.60-0.94 ACM: 1.21, 0.86-1.71 Non-CV death: 1.51, 0.99-2.31 https://t.co/X7Nl7ea9cm

Jun 20, 2023 · 6 likes · 3,253 followers View post →
Liz Highleyman
@LizHighleyman · X

In a study of ~5500 people w/ chronic coronary disease, colchicine reduced risk of heart attack, stroke, revascularization or death by ~30%, from 3.6 to 2.5 per 100 PY. It previously showed benefit for people who had already had a heart attack. 2/ https://t.co/BDIEf1IUFZ

Jun 20, 2023 · 4 likes · 16,156 followers View post →
Alex
@AxFS_MD · X

... o revascularización coronaria por isquemia y muerte cardiovascular fueron significativamente más bajos en el grupo de #Colchicina. Además, la incidencia de muerte por otras causas fue mayor con Colchicina (0.7 vs. 0.5 eventos/100k personas—año). https://t.co/rYg7tGOd9x

Jun 20, 2023 · 165 followers View post →
Faby G.
@Fabiolaghh · X

RT @javier20ch:

May 20, 2023 · 8 shares · 410 followers View post →
Eliud
@draquinomf · X

RT @javier20ch:

May 20, 2023 · 8 shares · 21 followers View post →
KatyMS
@katyaa_ms · X

RT @javier20ch:

May 18, 2023 · 8 shares · 232 followers View post →
IARETUSA
@IARETUSA · X

RT @javier20ch:

May 18, 2023 · 8 shares · 1,805 followers View post →
adinael colant
@adinaelcollant1 · X

RT @javier20ch:

May 18, 2023 · 8 shares · 1,003 followers View post →
Javi
@javier_jex · X

RT @javier20ch:

May 18, 2023 · 8 shares · 162 followers View post →
Fernando Olais
@FernandoOlais1 · X

RT @javier20ch:

May 18, 2023 · 8 shares · 17 followers View post →
diego romero cawen
@chinorigin · X

RT @javier20ch:

May 18, 2023 · 8 shares · 267 followers View post →
Dr. FEVI
@javier20ch · X

May 17, 2023 · 49 likes · 8 shares · 13,428 followers View post →
Aravind Mohanoor aravind_mc on Gettr
@aravindmc · X

turning severe C19 into asymptomatic C19, doesn't this STILL make a case for additional treatments after vaccination, especially with drugs which are already known to prevent heart issues?

Jan 16, 2023 · 967 followers View post →
Ronaldo Correa Fabiano
@Ronaldo_CFF · X

12/ For a median follow-up of 28.6 months, colchicine reduced major cardiovascular outcomes (cardiovascular death, spontaneous MI, stroke, or coronary revascularization). https://t.co/x08gU8MQ4W

Oct 30, 2022 · 6 likes · 832 followers View post →
Ali
@mirheum · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/iHmKc97I4M

Oct 21, 2022 · 116 followers View post →
Jake Johnson
@JakeJoh34423915 · X

@kevinnbass Thoughts on continuing colchicine indefinitely? https://t.co/OSekkVawz0

Jul 26, 2022 · 2 likes · 4 followers View post →
Mohamed E. Elrggal
@M_Elraggal · X

Always coming to my mind after the Colchicine in Patients with Chronic Coronary Disease study in @NEJM .. Why it is not colchicine/dexa after acute pyelonephritis? Then i found this @Ped_Neph: https://t.co/dLXlfeL1Zp No effect of dexa on kidney scarring after acute PN

May 21, 2022 · 1 like · 1,698 followers View post →
Cassidy Padgett
@Cassidy_Hope97 · X

RT @accpcardprn: Let's start a discussion about colchicine in CAD. We have some decent data showing improvement in outcomes for chronic and…

Jan 10, 2022 · 1 share · 202 followers View post →
ACCP Cardiology PRN
@accpcardprn · X

Let's start a discussion about colchicine in CAD. We have some decent data showing improvement in outcomes for chronic and acute CAD (see: https://t.co/JllJuLdxJm, https://t.co/zE48m7YtCB). Has anyone adopted this into practice? Why or why not? #CardioTwitter #Cardiology

Jan 10, 2022 · 23 likes · 1 share · 9,300 followers View post →
JK MD
@jksequoia · X

@davidasinclair @hubermanlab https://t.co/jP0pPt1LVh

Dec 28, 2021 · 256 followers View post →
John Damianos, M.D.
@john_damianosMD · X

@CatherineWangMD I’m definitely not a

Dec 21, 2021 · 3 likes · 23,846 followers View post →
Stella M Macin
@StellaMMacin · X

RT @StellaMMacin: Benefit of colchicine independent of timing of prior ACS Colchicine in Patients With Chronic Coronary Disease in Relation…

Oct 20, 2021 · 1 share · 550 followers View post →
Noordwest Academie
@noordwestac · X

Wetenschap in Noordwest: “Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome”: https://t.co/Ba0DaBIc1H @noordwestzh #wetenschapNoordwest #colchicine #AcuteCoronarySyndrome #samenbeter

Oct 6, 2021 · 128 followers View post →
Stella M Macin
@StellaMMacin · X

Benefit of colchicine independent of timing of prior ACS Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome TSJ et al., JACC. 2021

Sep 29, 2021 · 2 likes · 1 share · 550 followers View post →
Juliette Power
@JuliettePower44 · X

RT @CardioNerdsJC: To get situated: check out the powerful

Sep 14, 2021 · 2 shares · 644 followers View post →
CardioNerds Journal Club
@CardioNerdsJC · X

To get situated: check out the powerful

Sep 14, 2021 · 2 likes · 2 shares · 8,221 followers View post →
Hernandez Edgar
@Internistacl · X

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome https://t.co/am6sc1xa4P vía @practiceupdate

Sep 7, 2021 · 519 followers View post →
⭐⭐hector ⭐dionisio ⭐⭐ He/Him
@hekkifamilymed · X

RT @Reumaclinic: An old friend in Rheumatology, cheap with low toxicity and benefits over cardiovascular outcomes https://t.co/L6xwyTNJg7…

Sep 5, 2021 · 4 shares · 209 followers View post →
鯵ゼミ_Journal Club
@AJSR_since2005 · X

#047 Colchicine in Patients with Chronic Coronary Disease N Engl J Med 2020;383:1838-47.

Sep 4, 2021 · 6 followers View post →
СГАМ
@CGAM2016 · X

RT @PracUpCardio: Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome https://t.co/t2pWCnijUS…

Sep 4, 2021 · 1 share · 235 followers View post →
Cardiology
@PracUpCardio · X

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome https://t.co/t2pWCnijUS #cardiology

Sep 3, 2021 · 1 like · 1 share · 884 followers View post →
Jeffry Beltre E.
@Mr_Jeffry · X

RT @BebetoDice: @Mr_Jeffry @PhellixR Ojo , fallo en reducir el tamaño del infarto . Pero en enfermedad CV crónica redujo significativamente…

Sep 3, 2021 · 1 share · 2,055 followers View post →
Carlos García L.
@BebetoDice · X

@Mr_Jeffry @PhellixR Ojo , fallo en reducir el tamaño del infarto . Pero en enfermedad CV crónica redujo significativamente los eventos coronarios https://t.co/aByPyW52Js

Sep 3, 2021 · 1 share · 3,659 followers View post →
MasMaz
@MasMazCom · X

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome - https://t.co/FpEFRPWYTi

Aug 29, 2021 · 169 followers View post →
Dataemia
@Dataemia · X

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome - https://t.co/tHpj4Zxz5E

Aug 29, 2021 · 965 followers View post →
UPMC Mercy Internal Medicine Residency
@UPMCMercyIM · X

Today's #journalclub, good sample size, appropriate design. Not reflecting our patient population. How control study group are in #BP, #LDL #DM #Weight Interaction of #statin and #colchicine? Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/9awwgFIlXG

Jul 30, 2021 · 3 likes · 3,111 followers View post →
Faizan Ahmed MD
@FaizanA50147386 · X

https://t.co/Uvt42UErVA Do we have any guidelines on the base of this trial and how many cardiologist are giving their patients colchicine?? @American_Heart @JACCJournals

Jun 15, 2021 · 2 followers View post →
Ohio State Internal Medicine Residency
@OhioStateIMRes · X

@Toluhwalase Yes! The 3 studies Farouk presented on are below: 1) Long term BB therapy & clinical outcomes after acute MI https://t.co/ZpMfDPwHKx 2) Early Rhythm Control in AF https://t.co/oBCsEksugx 3) Colchicine in Chronic CAD https://t.co/iEMta0IQi9

Jun 14, 2021 · 3,628 followers View post →
Aviva Gabriel
@avivajazz · X

Colchicine in Patients with Chronic Coronary Disease | NEJM | #BotanicalMedicine https://t.co/JvkM4cNGX6

May 19, 2021 · 3,591 followers View post →
Chompunut Asava-aree
@asavachom · X

RT @CMichaelGibson: In a randomized trial of patients with chronic coronary disease, the risk of death, heart attack, stroke, or ischemia-d…

May 15, 2021 · 17 shares · 15 followers View post →
The Curbsiders
@thecurbsiders · X

Study 10: 'Colchicine in Patients with Chronic Coronary Disease' by Stefan Nidorf et al. @NEJM pub date Nov 5 2020; https://t.co/bHEluLgEX4 Bottom line: 4 pts w/ stable CAD on evidence-based tx for 2ndary prevention, low-dose colchicine may further⬇️risk of cardiovascular events.

Apr 22, 2021 · 3 likes · 50,327 followers View post →
Hossein Akbari
@hossein1410 · X

RT @WKSilverstein: We were then pleased to have @AmolAVerma present his top 5 GIM papers from 2020 (none on COVID!). They are linked below:…

Apr 13, 2021 · 1 share · 1,650 followers View post →
Billy Silverstein
@WKSilverstein · X

We were then pleased to have @AmolAVerma present his top 5 GIM papers from 2020 (none on COVID!). They are linked below:https://t.co/wWZuJR89Mo; https://t.co/l2XeSjKQ2T; https://t.co/EICyLFScuo; https://t.co/HVv9ZrIjf5; https://t.co/LWoz0cij6J; https://t.co/NE1NEPCDEz

Apr 13, 2021 · 9 likes · 1 share · 1,363 followers View post →
Jesús Palacio
@je_pala · X

RT @MBE_SMUMFYC: Ayer tuvimos una entretenida y formativa sesión #clublectura #lecturacritica @smumfyc @commurcia del ECA Colchicine in Pa…

Mar 19, 2021 · 3 shares · 6,041 followers View post →
Jose Miguel Bueno
@jmbo1964 · X

RT @MBE_SMUMFYC: Ayer tuvimos una entretenida y formativa sesión #clublectura #lecturacritica @smumfyc @commurcia del ECA Colchicine in Pa…

Mar 18, 2021 · 3 shares · 1,769 followers View post →
Professor M Z Khalil
@mzkhalil · X

Colchicine in Patients with Chronic Coronary Disease | NEJM Cost efficient compared to #canakinumab https://t.co/gLOmuhRqyu https://t.co/XdcIzs9K9J

Mar 6, 2021 · 2,856 followers View post →
Minnow Walsh, MD, MACC
@MinnowWalsh · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/pzQU4ug4W0 Under enrollment of women and underreporting of sex-specific AEs https://t.co/60S59nGVjT

Feb 28, 2021 · 1 like · 7,833 followers View post →
Patrycja Woźniak
@wozniakpatrycja · X

„In a randomized trial involving patients with chronic coronary disease, the risk of cardiovascular events was significantly lower among those who received 0.5 mg of colchicine once daily than among those who received placebo” | ⁦@NEJM⁩ https://t.co/f6dGwAqmHS

Feb 27, 2021 · 104 followers View post →
Ali Hussain, MD
@Aliissso · X

Will this change your practice? #colchicine #LoDoCo #CAD #MedTwitter https://t.co/ARW780yTM4

Feb 26, 2021 · 118 followers View post →
Daniele Rodolico
@DanieleRodolico · X

RT @MattiaGalli10: Check out our commentary to the LoDoCo2 trial. Colchicine has an antiplatelet effect that could explain both its effica…

Feb 26, 2021 · 1 share · 417 followers View post →
Mattia Galli
@MattiaGalli10 · X

Check out our commentary to the LoDoCo2 trial. Colchicine has an antiplatelet effect that could explain both its efficacy and the increased rate of non cardiovascular death. Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/mdfhfwxNen

Feb 25, 2021 · 8 likes · 1 share · 3,190 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/8V9n3AVNRw

Feb 25, 2021 · 2,712 followers View post →
Lucas Helal
@helal_lucas · X

@filipe_rafaeli @entregacorisco @mab_sp125 @JoaoUchoa16 @Roth69808472 @LemesGiuliano Colchicina me parece crível aqui: https://t.co/s9TQiqBwYj

Feb 13, 2021 · 1 like · 455 followers View post →
Dra. MarÍa Guadalupe Parra Machuca
@DraMariaParra · X

RT @ANCAM_MEXICO: Colchicina una vez al dia en sindrome coronario cronico, disminuye la muerte cardiovascular, infarto miocardio, evento va…

Feb 8, 2021 · 4 shares · 307 followers View post →
ANCAM México
@ANCAM_MEXICO · X

Colchicina una vez al dia en sindrome coronario cronico, disminuye la muerte cardiovascular, infarto miocardio, evento vascular cerebral o isquemia que lleva a revascularizacion, con HR 0.69 IC 0.57-0.83, p < 0.001. https://t.co/hnfq7sfJmY

Feb 8, 2021 · 10 likes · 4 shares · 11,035 followers View post →
Dr Ai Lyn Tan
@DrAiLynTan · X

RT @DrAiLynTan: #Colchicine reduces risk of #cardiovascular events in patients with #coronary disease ➡️31% lower relative risk of cardiov…

Jan 26, 2021 · 3 shares · 7,145 followers View post →
Arthur Morgan
@mad_surg · X

https://t.co/gPOZRxD9yW

Jan 25, 2021 · 203 followers View post →
Dr L Boominathan PhD
@DrLBoominathan · X

Given that colchicine is effective in treating COVID-19, the following finding is a good recall indeed. Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/LKMJCOaCAB

Jan 25, 2021 · 877 followers View post →
Dr L Boominathan PhD
@DrLBoominathan · X

Given that colchicine is effective in treating COVID-19, the following finding is a good recall indeed. Colchicine in Patients with Chronic Coronary Disease https://t.co/NTpPV3CVzf

Jan 25, 2021 · 877 followers View post →
David Arroyo
@dvdrry · X

@roi_cal A ver, entiendo tu preocupación,pero lo mismo lo mismo no es. La colchicina ha demostrado reducir mortalidad en cardiopatas... https://t.co/l0oMlrn4JD Y algo más de evidencia hay...

Jan 25, 2021 · 4 likes · 2,986 followers View post →
Mario Elia
@supermarioelia · X

@PharmacistMama Here's the most recent study. Haven't seen much adoption on the front lines yet. https://t.co/zPGHho2INM

Jan 23, 2021 · 2,871 followers View post →
Mo Baily
@mededu · X

@Links_Medicus @ELS_Cardiology This was published by NEJM Nov 2020 https://t.co/vesKJgv7cv

Jan 22, 2021 · 1 like · 654 followers View post →
movedoc
@movedoc · X

Colchicine in Patients with Chronic Coronary Disease https://t.co/EBg2c7SVfp

Jan 13, 2021 · 487 followers View post →
Caroline Blaine
@CarolineBlaine · X

6. RCT of 5522 with chronic coronary disease found a reduced risk of CV events with once daily colchicine compared with placebo https://t.co/FI7rnMIEca https://t.co/KnmftnDTB6

Jan 6, 2021 · 226 followers View post →
たま〜
@agrilus · X

コルヒチンが安定狭心症での心血管死抑制する報告が出たと言うことで処方増えるのかな? https://t.co/6HNy5WHtvi

Dec 30, 2020 · 3 likes · 602 followers View post →
Laura Goodliffe
@laura_goodliffe · X

RT @MacDeptMed: ICYMI: Dr. John W Eikelboom, the LoDoCo2 Trial Investigators et al. assessed the effects of #colchicine in patients with ch…

Dec 22, 2020 · 1 share · 561 followers View post →
McMaster University Department of Medicine
@MacDeptMed · X

ICYMI: Dr. John W Eikelboom, the LoDoCo2 Trial Investigators et al. assessed the effects of #colchicine in patients with chronic coronary disease. The risk of CV events was significantly lower among those who received 0.5 mg of colchicine once daily. #RCT https://t.co/6E8uJSBKTm https://t.co/ioLOfBDMkO

Dec 21, 2020 · 6 likes · 1 share · 4,146 followers View post →
Sol Abeytua
@SolAbeytua · X

RT @AbeytuaManuel: Colchicine in Patients with Chronic Coronary Disease, the risk of cardiovascular events was significantly lower among th…

Dec 9, 2020 · 4 shares · 3 followers View post →
Antonio Manteca
@amango30 · X

RT @RevistaMFSamfyc: Colchicina en pacientes con coronariopatía crónica https://t.co/YEX07P3GkB PMID 32865380

Dec 1, 2020 · 1 share · 138 followers View post →
Revista MFAndalucia
@RevistaMFSamfyc · X

Colchicina en pacientes con coronariopatía crónica https://t.co/YEX07P3GkB PMID 32865380

Nov 27, 2020 · 1 share · 722 followers View post →
sabelamacu
@tcae_farmacia · X

RT @FarmaciaHums: Colchicina 0.5mg diarios disminuye riesgo de eventos cardiovasculares en pacientes con enfermedad coronaria crónica | NE…

Nov 27, 2020 · 3 shares · 251 followers View post →
Paco Valls
@pacovr53 · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/eOS0Utet8Y

Nov 22, 2020 · 2,619 followers View post →
Ivan Mendoza
@mencardio · X

RT @mencardio: Colchicine in Patients With Chronic Coronary Disease | comment: Peter Libby MD https://t.co/0F0TdPQN2g @ivanovich13 @torresv…

Nov 20, 2020 · 11 shares · 7,257 followers View post →
João Alho
@reumalho · X

eu tou com esse artigo aqui aberto no navegador desde o dia que saiu e eu nao li uma linha ainda https://t.co/vLJMSiAwab

Nov 20, 2020 · 21 likes · 111,072 followers View post →
Joseph KAMTCHUM TATUENE
@JTatuene · X

RT @ChaturvediNeuro: New study shows that daily colchicine reduced major CV events in patients with coronary artery disease. ? potential fu…

Nov 20, 2020 · 2 shares · 608 followers View post →
Dr. Norteño
@DrNorteno · X

La evidencia de un ensayo reciente ha demostrado que los efectos antiinflamatorios de la colchicina reducen el riesgo de eventos cardiovasculares en pacientes con infarto de miocardio reciente. N Engl J Med 2020; 383: 1838-1847 DOI: 10.1056 / NEJMoa2021372 https://t.co/T2RzuLupZk

Nov 20, 2020 · 24 likes · 1 share · 6,299 followers View post →
岩手医科大学 脳神経内科・老年科
@IwateNeurol · X

RT @ChaturvediNeuro: New study shows that daily colchicine reduced major CV events in patients with coronary artery disease. ? potential fu…

Nov 19, 2020 · 2 shares · 1,019 followers View post →
john morley
@drjohnmorley · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/knJB4fNaMp

Nov 19, 2020 · 8,322 followers View post →
Sara Ortonobes
@petita_libelula · X

Colchicine in Patients with Chronic Coronary Disease https://t.co/4ns0Yye8oZ

Nov 18, 2020 · 388 followers View post →
名前
@akkiii0830 · X

https://t.co/lgYmjVFsDn Colchicine in Patients with Chronic Coronary Disease LoDoCo2

Nov 16, 2020 · 247 followers View post →
96mplf_
@96mplf_ · X

RT @NEJM: Original Article: Colchicine in Patients with Chronic Coronary Disease (LoDoCo2 Trial) #ESCCongress

Nov 15, 2020 · 86 shares · 130 followers View post →
John Morley
@Meddocslu · X

Colchicine in Patients with Chronic Coronary Disease | NEJM Amazing result. Much better than statins https://t.co/YjP3D4f2IN

Nov 11, 2020 · 1 like · 1,213 followers View post →
HERNANDO GARCIA
@garciaintensivo · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/lJdCQGLV2P

Nov 11, 2020 · 1 like · 285 followers View post →
Mihir Kelshiker
@Mihir_Kelshiker · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/KXdTFpTITf

Nov 11, 2020 · 202 followers View post →
Arturo Melgar Pliego
@drmelgar · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/tT2eMLmieM

Nov 11, 2020 · 2 likes · 355 followers View post →
Pankti Pandya
@pankti4299 · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 11, 2020 · 48 shares · 2,168 followers View post →
Alex Wehmeyer
@Alex855230 · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 11, 2020 · 48 shares · 137 followers View post →
Florin-Dan
@florindanpopesq · X

RT @Tuhina_Neogi: Just officially published - LoDoCo2: #Colchicine in Patients with Chronic Coronary Disease. Will treatment guidelines cha…

Nov 10, 2020 · 7 shares · 4,082 followers View post →
Debasish Banerjee
@debukidney · X

Very interesting Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/aJgIa7yWlO

Nov 10, 2020 · 4 likes · 363 followers View post →
nekonekoz
@nekonekoz · X

RT @Yohei_Kanzawa: ESCの頃にpublishされていた論文ですが、少量コルヒチンがこれからデフォルトになってくるのでしょうか。 慢性冠動脈疾患の患者で少量コルヒチンが心血管イベントを減少。 #CAD #コルヒチン Colchicine in Patient…

Nov 10, 2020 · 1 share · 806 followers View post →
Jonathan Misskey
@JonMisskey · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 9, 2020 · 48 shares · 294 followers View post →
Cure Cancer Now
@CancerCureNow · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/spFQkJIksH

Nov 9, 2020 · 6,926 followers View post →
Abderrazaq Chachi
@AbChachi21 · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 195 followers View post →
J. Enrique Martínez de la Plata
@enriquemplata · X

Colchicine in Patients with Chronic Coronary Disease | NEJM Resultados a tener en cuenta https://t.co/yqrCfxGBQc

Nov 7, 2020 · 1 like · 1,408 followers View post →
Ihsan Darmal
@DarmalIhsan · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 322 followers View post →
Saint Walter of Pontoise
@waltersavael · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 198 followers View post →
M José
@airamaneris · X

RT @AbeytuaManuel: Colchicine in Patients with Chronic Coronary Disease, the risk of cardiovascular events was significantly lower among th…

Nov 7, 2020 · 4 shares · 308 followers View post →
Juan Izquierdo García
@Juan__Izquierdo · X

RT @AbeytuaManuel: Colchicine in Patients with Chronic Coronary Disease, the risk of cardiovascular events was significantly lower among th…

Nov 7, 2020 · 4 shares · 885 followers View post →
Virgo Supercluster
@louverenge · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 50 followers View post →
Juanmarcosgg
@juanmarcosgg · X

RT @AbeytuaManuel: Colchicine in Patients with Chronic Coronary Disease, the risk of cardiovascular events was significantly lower among th…

Nov 7, 2020 · 4 shares · 510 followers View post →
Manuel Abeytua
@AbeytuaManuel · X

Colchicine in Patients with Chronic Coronary Disease, the risk of cardiovascular events was significantly lower among those who received 0.5 mg of colchicine once daily than among those who received placebo. | NEJM https://t.co/oW0UEWkpS7 https://t.co/kgjmOselAd

Nov 7, 2020 · 4 likes · 4 shares · 617 followers View post →
Jose De La Flor
@josedelaflor4 · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/pz6AdMgFFr

Nov 7, 2020 · 456 followers View post →
Eduardo Enriquez
@EnriquezEdwardo · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 760 followers View post →
Msc. Pedro Aguiar
@cardioaguiar · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 3,095 followers View post →
Diana Domingo Valero
@Diana_DoVa · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 505 followers View post →
Rodrigo Nunes Cal
@CalZole · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 3,973 followers View post →
Luis Caminal
@caminalm · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 966 followers View post →
MIЯVΛƬ #IC ༄ 。°
@mirvatalasnag · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 26,064 followers View post →
Linda
@wordfinga · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 4,595 followers View post →
John P Erwin III MD MBA MACC (#BigPoppy )
@HeartOTXHeartMD · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 39,658 followers View post →
José Miguel Torres Viera
@torresviera · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 7, 2020 · 48 shares · 6,093 followers View post →
Eduardo Argüelles González
@eddargo · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/OuyEvBeGYQ

Nov 7, 2020 · 3,312 followers View post →
Cristhian M.
@Otherside_Get · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 141 followers View post →
Hadyan
@HadyanHH · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 49 followers View post →
Yu-Hung Wang
@Wang_Yu_Hung · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 837 followers View post →
ERICK J. VAZQUEZ
@MDErickvzqz · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 154 followers View post →
carmen gm
@gm_carmen · X

RT @FormigaFrancesc: Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/yjEp2eOMY5 @AlbertAriza3 @Medtorek @ana_apiec…

Nov 6, 2020 · 3 shares · 151 followers View post →
Dr . Ahmed Algunaid
@algoneid · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 486 followers View post →
Ray Walley
@WalleyRay · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/BuBSczsRCA

Nov 6, 2020 · 7,484 followers View post →
Ezeonufo Chukwunonso
@Ezeonufo · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 1,363 followers View post →
William Lynch
@drwilliamlynch · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 1,194 followers View post →
Carles Falces
@CarlesFalces · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 2,691 followers View post →
Ashley Campbell, PharmD
@AshCampbell_Rx · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 258 followers View post →
Felix Nguyen
@BigCoachF · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 162 followers View post →
Ifeanyi Nsofor
@ekemma · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 21,121 followers View post →
Rocio González
@rociog_molina · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 374 followers View post →
LukeEKaewEKum |||
@ArchAugust_C · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 32 followers View post →
Avi Zi
@AZifroni · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 118 followers View post →
MadWolf18
@MadWolf18 · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 998 followers View post →
วันนี้ดีที่สุด
@TRGiUtQjafzzdW1 · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 120 followers View post →
Dr Mutonkole Jospin
@JoshMutonkole · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 51 followers View post →
Sergio Hevia
@SerHevNav · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 723 followers View post →
Pub Health Monitor
@monitor_PH · X

RT @NEJM: Visual Abstract: Colchicine in Patients with Chronic Coronary Disease

Nov 6, 2020 · 48 shares · 1,825 followers View post →
Tuhina Neogi, MD, PhD
@Tuhina_Neogi · X

RT @rheum_cat: @JYazdanyMD @UWRheum @r_burmester Nidorf, et al - LoDoCo2. https://t.co/Ae9G9ixSKG Colchicine in chronic CAD. Primary en…

Nov 5, 2020 · 1 share · 3,105 followers View post →
Rheum Cat
@rheum_cat · X

@JYazdanyMD @UWRheum @r_burmester Nidorf, et al - LoDoCo2. https://t.co/Ae9G9ixSKG Colchicine in chronic CAD. Primary endpoint: composite of CV death, nonfatal MI, CVA Benefit with colchicine, HR 0.69 https://t.co/rnb5UkS4qF #ACR20 #ACRambassador

Nov 5, 2020 · 2 likes · 1 share · 8,912 followers View post →
舛森 悠| Yu Masumori |総合診療
@Dr_mandheling · X

https://t.co/alwR038AC1

Nov 1, 2020 · 9,449 followers View post →
Airiau Caroline
@caroairiau · X

RT @pharmaciensAPES: Étude randomisée chez des patients avec maladie coronarienne chronique qui conclut que le risque d'événements cardiova…

Oct 20, 2020 · 1 share · 1,474 followers View post →
pharmaciensAPES
@pharmaciensAPES · X

Étude randomisée chez des patients avec maladie coronarienne chronique qui conclut que le risque d'événements cardiovasculaires est significativement plus faible chez ceux qui ont reçu 0,5 mg de colchicine par jour, par rapport ceux qui ont reçu un placebo https://t.co/D3PTS5CllO https://t.co/0eCB3AMl4l

Oct 20, 2020 · 1 like · 1 share · 895 followers View post →
Girish Narayan
@ErGirishN · X

https://t.co/eolKQWIWQa

Oct 4, 2020 · 123 followers View post →
横山暁子
@yokoakipp · X

RT @jiji_coffee: Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/F3K9DTubqV

Sep 19, 2020 · 1 share · 1,114 followers View post →
あちょ908
@acho908 · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/F3K9DTubqV

Sep 19, 2020 · 2 likes · 1 share · 865 followers View post →
イチマル
@ichimaruyongo · X

Colchicine in Patients with Chronic Coronary Disease https://t.co/EnEO73XShR

Sep 12, 2020 · 491 followers View post →
Filip Rega
@RegaFilip · X

RT @MacDeptMed: Dr. John Eikelboom (@johneikelboom) et al. conducted a randomized, controlled, double-blind trial to assess the effect of 0…

Sep 9, 2020 · 5 shares · 337 followers View post →
Marta #TEAMSTALLION
@RoaMarta23 · X

RT @vicatallah: Pacientes con enfermedad coronaria crónica mostró que ocurrencia de eventos cardiovasculares fue significativamente menor e…

Sep 8, 2020 · 5 shares · 39,278 followers View post →
Rafael Trinidad
@RafaelT60719381 · X

RT @vicatallah: Pacientes con enfermedad coronaria crónica mostró que ocurrencia de eventos cardiovasculares fue significativamente menor e…

Sep 7, 2020 · 5 shares · 175 followers View post →
Nezar Alsaeedi
@DrNezarAlsaeedi · X

RT @MacDeptMed: Dr. John Eikelboom (@johneikelboom) et al. conducted a randomized, controlled, double-blind trial to assess the effect of 0…

Sep 7, 2020 · 5 shares · 195 followers View post →
Alison Fox-Robichaud, MD
@drfoxrob · X

RT @MacDeptMed: Dr. John Eikelboom (@johneikelboom) et al. conducted a randomized, controlled, double-blind trial to assess the effect of 0…

Sep 7, 2020 · 5 shares · 3,006 followers View post →
Saurabh Gupta, MD MSc FRCSC
@soreabg · X

RT @MacDeptMed: Dr. John Eikelboom (@johneikelboom) et al. conducted a randomized, controlled, double-blind trial to assess the effect of 0…

Sep 7, 2020 · 5 shares · 2,124 followers View post →
cskappak
@cskappak · X

RT @JulianOwenEM_CC: https://t.co/wLf8NCcEpp

Sep 7, 2020 · 1 share · 748 followers View post →
Julian Owen
@JulianOwenEM_CC · X

https://t.co/wLf8NCcEpp

Sep 7, 2020 · 2 likes · 1 share · 1,065 followers View post →
David Brenes-Castro
@DavidBrenesMD · X

12/14 b) confirmation of previous findings in the larger LoDoCo2 trial (HR 0.69; 95% CI, 0.57 to 0.83; P<0.001) https://t.co/NEW7Q6JpQo https://t.co/BuzzjJcZkD

Sep 7, 2020 · 1 like · 141 followers View post →
William Harper
@wlharper1 · X

RT @MacDeptMed: Dr. John Eikelboom (@johneikelboom) et al. conducted a randomized, controlled, double-blind trial to assess the effect of 0…

Sep 7, 2020 · 5 shares · 958 followers View post →
McMaster University Department of Medicine
@MacDeptMed · X

Dr. John Eikelboom (@johneikelboom) et al. conducted a randomized, controlled, double-blind trial to assess the effect of 0.5mg of colchicine once daily in chronic coronary disease. @PHRIresearch @HEI_mcmaster @McMasterGIM https://t.co/gdtTUS2ptJ

Sep 7, 2020 · 13 likes · 5 shares · 4,146 followers View post →
Doña Fior
@FiorDona · X

RT @vicatallah: Pacientes con enfermedad coronaria crónica mostró que ocurrencia de eventos cardiovasculares fue significativamente menor e…

Sep 7, 2020 · 5 shares · 125 followers View post →
Rafael Trinidad
@rtrinidad01981 · X

RT @vicatallah: Pacientes con enfermedad coronaria crónica mostró que ocurrencia de eventos cardiovasculares fue significativamente menor e…

Sep 7, 2020 · 5 shares · 247 followers View post →
F R Trujillo-Perdomo
@DomrepTrujillo · X

RT @vicatallah: Pacientes con enfermedad coronaria crónica mostró que ocurrencia de eventos cardiovasculares fue significativamente menor e…

Sep 7, 2020 · 5 shares · 926 followers View post →
Victor Atallah
@vicatallah · X

Pacientes con enfermedad coronaria crónica mostró que ocurrencia de eventos cardiovasculares fue significativamente menor en aquellos que recibieron colchicina en dosis bajas en comparación con placebo #VEA https://t.co/nUkSMPFbqn https://t.co/fw4gIBM1oy

Sep 7, 2020 · 17 likes · 5 shares · 42,152 followers View post →
pinacol
@pinacol · X

【RCT】慢性冠動脈疾患患者へのコルヒチン投与は、プラセボ投与と比較して、心血管死亡、自然発生の心筋梗塞、虚血性脳卒中や虚血による冠血行再建術のリスクを減少させた。 #ペ読 https://t.co/H9CuNU39cp

Sep 5, 2020 · 1,616 followers View post →
黃繼賢(CHI HSIEN HUANG) Jeff
@evaairgigaa · X

Colchicine' CV benefits are mixed, and the risk of non-CV death seems greater. https://t.co/OkSkKfpvDi https://t.co/OvCg51jWDE https://t.co/3o9gTjMXsD

Sep 1, 2020 · 79 followers View post →
Maria Varela
@Maria_Var_Cal · X

RT @caminalm: Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/iIam9psREA

Aug 31, 2020 · 2 shares · 1,253 followers View post →
Silvia Suárez
@SilviaPorto88 · X

RT @caminalm: Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/iIam9psREA

Aug 31, 2020 · 2 shares · 269 followers View post →
Luis Caminal
@caminalm · X

Colchicine in Patients with Chronic Coronary Disease | NEJM https://t.co/iIam9psREA

Aug 31, 2020 · 2 likes · 2 shares · 966 followers View post →